TIDMMED

Medaphor Group PLC

07 February 2018

MedaPhor Group plc

("MedaPhor" or the "Group" or the "Company")

Investor presentation

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that it will be presenting at the Shares and AJ Bell Spotlight Evening in London on Tuesday 13 February 2018.

The Shares and AJ Bell Investor evening provides an opportunity for Directors to make a presentation and talk about their company business plans for 2018 direct to existing and potential investors.

The event will commence at 6pm at Novotel Tower Bridge, London, EC3N 2NR. At the event CEO Stuart Gall will deliver a presentation detailing the Company's strategy following the recent acquisition of Intelligent Ultrasound Limited, along with an overview of the Company, where it is currently positioned and their plans for the future.

If you are interested in attending the event and would like information on how to register please contact Walbrook PR at medaphor@walbrookpr.com

The presentation will contain no new material information and is available on the Company's website: http://investors.medaphor.com/

Enquiries:

 
 MedaPhor Group plc                             www.medaphor.com 
 Stuart Gall, CEO                            Tel: +44 (0)29 2075 
  Nicholas Sleep, CTO                                       6534 
 
 Cenkos Securities                           Tel: +44 (0)20 7397 
                                                            8900 
 Camilla Hume/Bobbie Hilliam 
  (Nominated Advisor) 
 Michael Johnson / Julian 
  Morse (Corporate Broking) 
 
 Walbrook PR                         Tel: +44 (0)20 7933 8780 or 
                                         medaphor@walbrookpr.com 
 Paul McManus / Anna             Mob: +44 (0)7980 541 893 / Mob: 
  Dunphy                                     +44 (0)7876 741 001

About MedaPhor (www.medaphor.com)

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, develops advanced hi-fidelity haptic and manikin based training simulators, clinical image analysis software tools, augmented reality based needle guidance software and artificial intelligence based automated scanning software for all medical practitioners.

Based in Cardiff and Oxford in the UK and Atlanta in the US, MedaPhor is split into two divisions:

Ultrasound Simulation and Training

Focuses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer(TM) OBGYN and General Medical simulator training platform, the HeartWorks(TM) echocardiography simulator platform and the BodyWorks Eve(TM) Point-of-Care simulator platform (launching January 2018). Over 500 MedaPhor simulators have been sold to over 300 medical institutions in over 30 countries around the world.

Intelligent Ultrasound

Focuses on developing augmented reality and deep-learning based algorithms to make ultrasound machines smarter and more accessible. ScanNav(TM) uses machine-learning based algorithms to automatically identify and grade ultrasound images to provide scan assessment and audit of obstetric scanning. NeedleGuide(TM) aims to simplify ultrasound-guided needling by using deep learning and augmented reality to provide the user with pathway guidance and automated tracking for a range of medical procedures.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAEAXAKELAPEFF

(END) Dow Jones Newswires

February 07, 2018 02:00 ET (07:00 GMT)

Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Intelligent Ultrasound Charts.
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Intelligent Ultrasound Charts.